Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Yiping He
Affiliation
ORCID
Career Start Year
2002
Papers
63
H Index
32
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
35184277
Joint gene network construction by single-cell RNA sequencing data.
Biometrics
2023
37760589
Repurposing Clemastine to Target Glioblastoma Cell Stemness.
Cancers (Basel)
2023
36828904
Rewiring of the N-Glycome with prostate cancer progression and therapy resistance.
NPJ Precis Oncol
2023
37131619
Interplay between and mutations governs innate immune responses in diffuse gliomas.
2023
36752189
Oncofetal protein glypican-3 is a biomarker and critical regulator of function for neuroendocrine cells in prostate cancer.
J Pathol
2023
35264604
MTAP loss correlates with an immunosuppressive profile in GBM and its substrate MTA stimulates alternative macrophage polarization.
Scientific Reports
2022
35453502
Purine Synthesis Inhibitor L-Alanosine Impairs Mitochondrial Function and Stemness of Brain Tumor Initiating Cells.
Biomedicines
2022
34732238
TP53 wild-type/PPM1D mutant diffuse intrinsic pontine gliomas are sensitive to a MDM2 antagonist.
Acta neuropathologica communications
2021
33753479
A glutaminase isoform switch drives therapeutic resistance and disease progression of prostate cancer.
Proc Natl Acad Sci U S A
2021
33583275
Low levels of BRCA1 protein expression predict a worse prognosis in stage I-II colon cancer.
International Journal of Biological Markers
2021
33441554
Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy.
Nat Commun
2021
34521764
Epigenetic Regulation of Fanconi Anemia Genes Implicates PRMT5 Blockage as a Strategy for Tumor Chemosensitization.
Molecular Cancer Research
2021
32555164
The integrated genomic and epigenomic landscape of brainstem glioma.
Nature Communications
2020
32229503
Targeting Mutant PPM1D Sensitizes Diffuse Intrinsic Pontine Glioma Cells to the PARP Inhibitor Olaparib.
Molecular Cancer Research
2020
31533041
A PRMT5-RNF168-SMURF2 Axis Controls H2AX Proteostasis.
Cell Reports
2019
31801883
Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer.
Sci Transl Med
2019
30346624
Sensitive and rapid detection of TERT promoter and IDH mutations in diffuse gliomas.
Neuro-Oncology
2019
30478739
Hereditary brain tumor with a homozygous germline mutation in PMS2: pedigree analysis and prenatal screening in a family with constitutional mismatch repair deficiency (CMMRD) syndrome.
Familial Cancer
2019
31292202
CRISPR Editing of Mutant IDH1 R132H Induces a CpG Methylation-Low State in Patient-Derived Glioma Models of G-CIMP.
Molecular Cancer Research
2019
31040154
MTAP Loss Promotes Stemness in Glioblastoma and Confers Unique Susceptibility to Purine Starvation.
Cancer Research
2019
29802247
The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma.
Nat Commun
2018
30131529
Mutant allele quantification reveals a genetic basis for TP53 mutation-driven castration resistance in prostate cancer cells.
Sci Rep
2018
29097607
Adaptive Evolution of the GDH2 Allosteric Domain Promotes Gliomagenesis by Resolving IDH1-Induced Metabolic Liabilities.
Cancer Research
2018
28148827
Mutant IDH1 Disrupts the Mouse Subventricular Zone and Alters Brain Tumor Progression.
Molecular Cancer Research
2017
28939681
Loss Promotes Gliomagenesis via Aberrant Neural Stem Cell Proliferation and Differentiation.
Cancer Research
2017
29100338
Patient-derived DIPG cells preserve stem-like characteristics and generate orthotopic tumors.
Oncotarget
2017
27481176
Alternative Splicing Provides a Novel Molecular Mechanism for Prostatic Small-cell Neuroendocrine Carcinoma.
Eur Urol
2017
27803045
Molecular Signature to Risk-Stratify Prostate Cancer of Intermediate Risk.
Clin Cancer Res
2017
26506520
Prevalence of deleterious ATM germline mutations in gastric cancer patients.
Oncotarget
2015
24880341
Exome sequencing identifies somatic gain-of-function PPM1D mutations in brainstem gliomas.
Nature Genetics
2014
24140581
The genetic landscape of anaplastic astrocytoma.
Oncotarget
2014
23659599
Clinico-pathological description of three paediatric medulloblastoma cases with MLL2/3 gene mutations.
Neuropathol Appl Neurobiol
2014
24722048
Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas.
Oncotarget
2014
25198066
Chromatin accessibility mapping identifies mediators of basal transcription and retinoid-induced repression of OTX2 in medulloblastoma.
PLoS One
2014
23204232
Disruption of wild-type IDH1 suppresses D-2-hydroxyglutarate production in IDH1-mutated gliomas.
Cancer Research
2013
24240169
KMT2D maintains neoplastic cell proliferation and global histone H3 lysine 4 monomethylation.
Oncotarget
2013
23530248
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal.
Proc Natl Acad Sci U S A
2013
23045699
Global identification of MLL2-targeted loci reveals MLL2's role in diverse signaling pathways.
Proc Natl Acad Sci U S A
2012
22885298
Mutant IDH1 is required for IDH1 mutated tumor cell growth.
Oncotarget
2012
22869205
Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas.
Oncotarget
2012
22558385
Aberrant Otx2 expression enhances migration and induces ectopic proliferation of hindbrain neuronal progenitor cells.
PLoS One
2012
21719641
Altered telomeres in tumors with ATRX and DAXX mutations.
Science
2011
21163964
The genetic landscape of the childhood cancer medulloblastoma.
Science
2011
21289278
Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome.
Proceedings of the National Academy of Sciences of the United States of America
2011
20200521
Heteroplasmic mitochondrial DNA mutations in normal and tumour cells.
Nature
2010
19605688
Pre-TCR signaling inactivates Notch1 transcription by antagonizing E2A.
Genes and Development
2009
19684580
Sensitive digital quantification of DNA methylation in clinical samples.
Nature Biotechnology
2009
18495772
Primary human hepatocytes are susceptible to infection by hepatitis delta virus assembled with envelope proteins of woodchuck hepatitis virus.
Journal of Virology
2008
19056939
The antisense transcriptomes of human cells.
Science
2008
17671232
Distinct gene expression profiles of acute myeloid/T-lymphoid leukemia with silenced CEBPA and mutations in NOTCH1.
Blood
2007
1 - 50 of 63
Column Actions
Search
Recommended Authors
Collaborators
Hai Yan
Co-authored papers
31
Darell D Bigner
Co-authored papers
23
Roger E McLendon
Co-authored papers
20
Kenneth W Kinzler
Co-authored papers
11
Bert Vogelstein
Co-authored papers
11
Henry S Friedman
Co-authored papers
10
Nickolas Papadopoulos
Co-authored papers
8
Zachary J Reitman
Co-authored papers
7
Jiaoti Huang
Duke University School of Medicine
Co-authored papers
7
B K Rasheed
Co-authored papers
7
Stephen T Keir
Co-authored papers
6
Victor E Velculescu
Co-authored papers
6
Eric S Lipp
Co-authored papers
5
Siân Jones
Co-authored papers
4
Meng Li
Co-authored papers
4
Chetan Bettegowda
Co-authored papers
4
Gregory J Riggins
Co-authored papers
4
Suely Kazue Nagahashi Marie
Co-authored papers
3
Matthew Wortham
Pediatric Diabetes Research Center, University of California
Co-authored papers
3
Fausto J Rodriguez
University of California Los Angeles
Co-authored papers
3
Sueli Mieko Oba-Shinjo
Co-authored papers
3
Roel G W Verhaak
Yale School of Medicine
Co-authored papers
2
Gary L Gallia
Co-authored papers
2
Peter C Burger
Co-authored papers
2
Rebecca J Leary
Co-authored papers
2
Sanford D Markowitz
Co-authored papers
2
George I Jallo
Co-authored papers
2
Gerald A Grant
Brigham and Women's Hospital, Harvard Medical School
Co-authored papers
2
Hannah Carter
University of California San Diego
Co-authored papers
1
Jane E Minturn
Co-authored papers
1
1 - 30